Transcription of chapter 35 Pharmacovigilance - WHO
{{id}} {{{paragraph}}}
Example: bankruptcy
chapter 35 Pharmacovigilance - WHO
chapter 35 PharmacovigilanceSummary What is Pharmacovigilance and why is it important? Adverse drug reactions Medication errors Adverse drug Designing a Pharmacovigilance system activities at the facility level Pharmacovigilance activities at the national level Pharmacovigilance activities as part of public health programs Pharmacovigilance activities at the international Data collection data collection Mandatory data collection Active data collection Data collection Data analysis and reporting Taking actions for improvement and further readings guide 35-1 Analysis of medication errors in a hospital, 2005 35-2 Relationship of medication safety terms 35-3 Pharmacovigilance and the pharmaceutical management framework 35-4 The Pharmacovigilance framework 35-5 Nonvoluntary data collection tool for Pharmacovigilance 35-6 Sample ADE/product quality problem form from Zambia 35-1 Definitions of terms related to Pharmacovigilance 35-2 Determining ADR probability using indicators 35-3 Dangerous abbreviations 35-4 Roles and responsibilities of partners in Pharmacovigilance 3
chapter 35 Pharmacovigilance Summary 35.2 35.1 What is pharmacovigilance and why is it important? 35.2 Adverse drug reactions • Medication errors •
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Pharmacovigilance Systems ANALYSIS in Five, Analysis, Pharmacovigilance systems in five asian countries, Certified Pharmaceutical Good Manufacturing, Quality Risk Management in Pharmaceutical, Quality Risk Management in Pharmaceutical Industry, Mg tablets Olanzapine, Build Risk Management into Clinical, Patient monitoring guidelines for hiv, World health organization